Ontario Brain Institute

NeuroQore, Inc. is a Canadian company based in Ottawa, founded in 2012, that specializes in developing innovative neuromodulation treatment systems aimed at addressing treatment-resistant depression and related neurobehavioral conditions. The company's flagship product is a monophasic repetitive transcranial magnetic stimulation system that utilizes a unique semiconductor switch to emit a novel magnetic pulse. This technology is designed to help patients overcome challenges associated with major depressive disorder and suicidality, ultimately improving their quality of life. NeuroQore collaborates with leading universities and research clinics globally, reflecting its commitment to advancing the field of neuromodulation and transforming the lives of those affected by these debilitating disorders.

Diamond Therapeutics is a Toronto-based company dedicated to developing novel therapies for mental health conditions. It focuses on harnessing the potential of psychedelic compounds, specifically sub-perceptual, non-hallucinogenic treatments, aiming to benefit a wide range of patients and maximize positive impact on global mental health.

Epineuron Technologies, Inc. is a medical device company based in Hamilton, Canada, established in 2016. It specializes in developing innovative treatment strategies for peripheral nerve injuries through bioelectronic medicine. The company focuses on creating a suite of surgical solutions aimed at enhancing the repair and regeneration of peripheral nerves. Epineuron's flagship product is an electroceutical device that delivers targeted electrical stimulation to accelerate the natural healing processes of injured nerves. By leveraging this technology, Epineuron aims to set a new standard of care in the field of nerve injury treatment, aspiring to become a leader in bioelectronic nerve care.

NeuroQore, Inc. is a Canadian company based in Ottawa, founded in 2012, that specializes in developing innovative neuromodulation treatment systems aimed at addressing treatment-resistant depression and related neurobehavioral conditions. The company's flagship product is a monophasic repetitive transcranial magnetic stimulation system that utilizes a unique semiconductor switch to emit a novel magnetic pulse. This technology is designed to help patients overcome challenges associated with major depressive disorder and suicidality, ultimately improving their quality of life. NeuroQore collaborates with leading universities and research clinics globally, reflecting its commitment to advancing the field of neuromodulation and transforming the lives of those affected by these debilitating disorders.

Founded in 2017, Curv Health is a virtual clinic that empowers healthcare providers to establish and manage their own practices. It offers a platform connecting patients with registered professionals, including physiotherapists, dietitians, psychotherapists, and counselors, focusing on mental health and performance coaching.

Sound Options Tinnitus Treatments Inc. is a health technology company based in Ancaster, Canada, specializing in the development of software for tinnitus management. Founded in 2012, the company offers clinically tested, individually tailored sound therapy designed to alleviate the symptoms of tinnitus, a challenging hearing disorder that affects approximately ten percent of the population. Utilizing advanced computational neuroscience and tinnitus research, the company's software creates customized treatment plans based on each client's audiogram and tinnitus profile. The effectiveness of Sound Options' approach has been validated through studies conducted at McMaster University. The company has also formed partnerships with various independent and franchised hearing clinics across Canada to enhance accessibility for tinnitus patients and hearing healthcare professionals.